DG DISPATCH - AACAP: Deprenyl May Result In AD/HD Symptom Improvements
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




DG DISPATCH - AACAP: Deprenyl May Result In AD/HD Symptom Improvements

By Lara Pullen
Special to DG News

CHICAGO, IL -- October 26, 1999 -- Some children do not respond to the stimulant medication that is frequently prescribed for attention deficit/hyperactivity disorder (AD/HD). Deprenyl (a monamine oxidase inhibitor - type B drug) is traditionally prescribed for the treatment of Parkinson’s Disease, but a new study suggests that it may be able to help these AD/HD children.

Dr. Molly A. Malone, of The Hospital for Sick Children, in Toronto, presented the results of a double-blind, placebo-controlled pilot project at the 46th annual meeting of the American Academy of Child and Adolescent Psychiatry. The results of this study built upon previous findings from a non-controlled study that demonstrated the benefits of deprenyl in children diagnosed with AD/HD.

Ten children (ages six to 13) with AD/HD participated in the study. These children had very severe AD/HD and presented many co-morbid problems. Placebo and deprenyl tablets (5 mg) were given twice a day for one month each.

Results showed that three tasks were significantly improved (paired-associate learning, math computation and Beery shape copying) with deprenyl treatment as determined by a two-tailed statistical test. This pilot study indicates that deprenyl may have some benefits for the task performance and classroom behavior of some children with AD/HD.

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities